Synaptogenix Inc (SNPX)

[Cyosol]

They are completely blind until they receive all the preliminary data at once around early November and it would be foolish to attribute stock price movements to "leaks" before then.

Patients only receive the drug for 6 months. I think the 10 month data won't be as relevant because it will show how both groups do after 4 additional months on no drug.

As for the valuation, you could be right that a lot of angsty investors will take their money and run as soon as possible after results, but those will then be replaced by new investors that may not be as eager to sell until the valuation reaches a more appropriate level.

There's a reason for why the company is worth $60 million right now and it's because of the risk and uncertainty of not knowing whether the drug actually works. Maybe it doesn't, but if it does, why would you sell it for less than $1 billion?

Even Haywood thinks good results are worth at least $5 billion.